These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6010299

  • 21. [Changes in sensitivity to chlorpromazine of instrumental avoidance response in rats: simple conditioning and discrimination].
    Bignami G, Carro G.
    Ann Ist Super Sanita; 1967; 3(1):35-44. PubMed ID: 5619272
    [No Abstract] [Full Text] [Related]

  • 22. Central effects of an inhibitor of tyrosine hydroxylation.
    Corrodi H, Hanson LC.
    Psychopharmacologia; 1966; 10(2):116-25. PubMed ID: 5982985
    [No Abstract] [Full Text] [Related]

  • 23. Effects of chlorpromazine on the acquisition of a wheel-turning avoidance response.
    Bravo L, Appel JB.
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):451-8. PubMed ID: 6031476
    [No Abstract] [Full Text] [Related]

  • 24. Brain catecholamines modifications. The effects on memory facilitation induced by oxotremorine in mice.
    Huygens P, Baratti CM, Gardella JL, Filinger E.
    Psychopharmacology (Berl); 1980 Feb; 69(3):291-4. PubMed ID: 6774370
    [Abstract] [Full Text] [Related]

  • 25. Behavioral, biochemical, and pharmacological effects of chronic dosage of phenothiazine tranquilizers in rats.
    Maickel RP, Braunstein MC, McGlynn M, Snodgrass WR, Webb RW.
    Adv Biochem Psychopharmacol; 1974 Feb; 9(0):593-602. PubMed ID: 4836224
    [No Abstract] [Full Text] [Related]

  • 26. Antiparkinsonian drugs and central dopamine neurons.
    Fuxe K, Goldstein M, Ljungdahl A.
    Life Sci I; 1970 Jul 15; 9(14):811-24. PubMed ID: 5478392
    [No Abstract] [Full Text] [Related]

  • 27. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A, Koe BK, Tenen SS.
    J Pharmacol Exp Ther; 1966 Mar 15; 151(3):339-52. PubMed ID: 5938473
    [No Abstract] [Full Text] [Related]

  • 28. Effects of chlorpromazine on two types of conditioned avoidance behavior.
    Dobrin PB, Rhyne RL.
    Arch Int Pharmacodyn Ther; 1969 Apr 15; 178(2):351-6. PubMed ID: 5355566
    [No Abstract] [Full Text] [Related]

  • 29. Psychopharmacological profile of molindone.
    Rubin AA, Yen HC, Pfeffer M.
    Nature; 1967 Nov 11; 216(5115):578-9. PubMed ID: 4966848
    [No Abstract] [Full Text] [Related]

  • 30. The disruption of conditioned avoidance response following selective depletion of brain catechol amines.
    Hanson LC.
    Psychopharmacologia; 1965 Jul 28; 8(2):100-10. PubMed ID: 5853733
    [No Abstract] [Full Text] [Related]

  • 31. Proceedings: Animal models for identifying new types of antipsychotic drugs.
    Ray OS.
    Psychopharmacol Bull; 1974 Oct 28; 10(4):19-20. PubMed ID: 4431861
    [No Abstract] [Full Text] [Related]

  • 32. Role of catecholaminesi in compulsive gnawing behaviour in mice.
    Pedersen V.
    Br J Pharmacol; 1968 Sep 28; 34(1):219P-220P. PubMed ID: 5692084
    [No Abstract] [Full Text] [Related]

  • 33. Catecholamine-independent behavioral and neurochemical effects of cocaine in rats.
    Gale K.
    NIDA Res Monogr; 1984 Sep 28; 54():323-32. PubMed ID: 6099878
    [No Abstract] [Full Text] [Related]

  • 34. Effect of benzquinamide on conditioned avoidance response and brain monoamine levels in the cat.
    Andén NE, Hanson L.
    Psychopharmacologia; 1966 Sep 28; 10(2):110-5. PubMed ID: 6013801
    [No Abstract] [Full Text] [Related]

  • 35. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
    Corrodi H, Fuxe K, Ljungdahl A, Ogren SO.
    Brain Res; 1970 Dec 18; 24(3):451-70. PubMed ID: 5494534
    [No Abstract] [Full Text] [Related]

  • 36. Blockade of the psychotic syndrome caused by nialamide in mice.
    Corrodi H.
    J Pharm Pharmacol; 1966 Mar 18; 18(3):197-9. PubMed ID: 4381221
    [No Abstract] [Full Text] [Related]

  • 37. Modification of the effects of antipsychotic agents on the "open field" performance of rats by treatment with -methyl tyrosine or p-chlorophenylalanine.
    Bapna JS, Dandiya PC.
    Psychopharmacologia; 1970 Mar 18; 17(5):361-6. PubMed ID: 4256843
    [No Abstract] [Full Text] [Related]

  • 38. [Psychopharmacological studies of a new tranquilizer, thiothixene (Navane)].
    Ueki S, Ogawa N, Kamata O, Gomita Y, Araki Y.
    Igaku Kenkyu; 1969 Nov 18; 39(5):434-53. PubMed ID: 5393785
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.